- Home
- MDGL vs VERX Comparison
MDGL vs VERX Comparison
Compare MDGL & VERX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDGL
- VERX
- Stock Information
- Founded
- MDGL 2011
- VERX 1978
- Country
- MDGL United States
- VERX United States
- Employees
- MDGL N/A
- VERX N/A
- Industry
- MDGL Biotechnology: Pharmaceutical Preparations
- VERX Computer Software: Prepackaged Software
- Sector
- MDGL Health Care
- VERX Technology
- Exchange
- MDGL Nasdaq
- VERX Nasdaq
- Market Cap
- MDGL 6.1B
- VERX 6.6B
- IPO Year
- MDGL N/A
- VERX 2020
- Fundamental
- Price
- MDGL $314.31
- VERX $34.48
- Analyst Decision
- MDGL Strong Buy
- VERX Buy
- Analyst Count
- MDGL 9
- VERX 12
- Target Price
- MDGL $420.63
- VERX $50.18
- AVG Volume (30 Days)
- MDGL 282.4K
- VERX 1.5M
- Earning Date
- MDGL 08-06-2025
- VERX 08-06-2025
- Dividend Yield
- MDGL N/A
- VERX N/A
- EPS Growth
- MDGL N/A
- VERX N/A
- EPS
- MDGL N/A
- VERX N/A
- Revenue
- MDGL $317,383,000.00
- VERX $687,057,000.00
- Revenue This Year
- MDGL $286.17
- VERX $16.77
- Revenue Next Year
- MDGL $64.17
- VERX $14.58
- P/E Ratio
- MDGL N/A
- VERX N/A
- Revenue Growth
- MDGL N/A
- VERX 15.20
- 52 Week Low
- MDGL $200.63
- VERX $30.26
- 52 Week High
- MDGL $377.46
- VERX $60.71
- Technical
- Relative Strength Index (RSI)
- MDGL 64.53
- VERX 39.75
- Support Level
- MDGL $284.02
- VERX $34.05
- Resistance Level
- MDGL $311.21
- VERX $36.68
- Average True Range (ATR)
- MDGL 11.94
- VERX 1.30
- MACD
- MDGL 2.74
- VERX 0.14
- Stochastic Oscillator
- MDGL 100.00
- VERX 36.51
About MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.
About VERX Vertex Inc.
Vertex Inc is a provider of tax technology and services. Its software, content, and services help customers stay in compliance with indirect taxes that occur in taxing jurisdictions all over the world. Vertex provides cloud-based and on-premise solutions to specific industries for every line of tax, including income, sales, consumer use, value-added, and payroll. The company offers solutions such as tax determination, Tax Data Management, document management, and compliance and reporting among others. The company derives revenue from software subscriptions.